HEFEI -- China has hit another milestone in the development of its next-generation "artificial sun," with one of its key ...

The center, which broke ground in 2023 in the Beijing Economic-Technological Development Area — aka Beijing E-Town — is the ...

Kelun-Biotech has become the second drugmaker to bring a TROP2-directed antibody-drug conjugate to regulatory approval, getting a green light in China for sacituzumab tirumotecan (sac-TMT).

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the ... 2024 forecasts for the drug, but reined them in again ...

China will refine its centralized drug procurement policy, an official report said on Wednesday, after a recent probe into quality concerns of off-patent medicines approved for distribution to public ...

China has already retaliated with tariffs of its own, and Canada has promised new tariffs on US goods in response to the ...

Starting just past midnight, imports from Canada and Mexico are now to be taxed at 25%, with Canadian energy products getting ...

Mexico and China didn't immediately detail any retaliatory ... the warnings of mainstream economists and put his own public approval on the line, believing that tariffs can fix what ails the ...

The move impacts products from Mexico, Canada and China-- the three largest trading ... the two countries regarding border security and drug trafficking. Here’s what to know about the tariffs ...

Insilico Medicine founder and CEO Alex Zhavoronkov told BioWorld that he tries to spend as much time as possible in China, because that's where the artificial intelligence (AI) drug development ...

Data and security laws are affecting scientists who stayed in China after COVID — but for some it’s still a great place to do ...